Protection of Neurons from Apoptosis by Apolipoprotein E-containing Lipoproteins Does Not Require Lipoprotein Uptake and Involves Activation of Phospholipase Cγ1 and Inhibition of Calcineurin*

Apolipoprotein E-containing lipoproteins (LpE) are generated in the central nervous system by glial cells, primarily astrocytes, and are recognized as key players in lipid metabolism and transport in the brain. We previously reported that LpE protect retinal ganglion neurons from apoptosis induced by withdrawal of trophic additives (Hayashi, H., Campenot, R. B., Vance, D. E., and Vance, J. E. (2007) J. Neurosci. 27, 1933–1941). LpE bind to low density lipoprotein receptor-related protein-1 and initiate a signaling pathway that involves activation of protein kinase Cδ and inhibition of the pro-apoptotic glycogen synthase kinase-3β. We now show that uptake of LpE is not required for the neuroprotection. Experiments with inhibitors of phospholipase Cγ1 and RNAi knockdown studies demonstrate that activation of phospholipase Cγ1 is required for the anti-apoptotic signaling pathway induced by LpE. In addition, the protein phosphatase-2B, calcineurin, is involved in a neuronal death pathway induced by removal of trophic additives, and LpE inhibit calcineurin activation. LpE also attenuate neuronal death caused by oxidative stress. Moreover, physiologically relevant apoE3-containing lipoproteins generated by apoE3 knock-in mouse astrocytes more effectively protect neurons from apoptosis than do apoE4-containing lipoproteins. Because inheritance of the apoE4 allele is the strongest known genetic risk factor for Alzheimer disease, the reduced neuroprotection afforded by apoE4-containing LpE might contribute to the neurodegeneration characteristic of this disease.

The lipoprotein composition of cerebrospinal fluid differs from that of plasma because the blood-brain barrier prevents the movement of lipoproteins from the peripheral circulation into the central nervous system (CNS) 3 (1). The CNS contains a distinct population of lipoprotein particles that are generated within the CNS and are thought to play important roles in the metabolism and transport of lipids within the brain. These lipoproteins are the size and density of plasma high density lipoproteins and contain apolipoprotein (apo) E and apoJ as their major protein constituents (2)(3)(4)(5). The apoE-containing lipoproteins (LpE) in the CNS are generated by non-neuronal glial cells, primarily astrocytes (5). Astrocytes are thought to provide nutrient support for neurons by delivering lipoproteins to neurons for axonal growth (6) and synaptogenesis (7). Interest in the function of apoE in the nervous system has blossomed recently because after nerve injury the synthesis of apoE dramatically increases (by up to 150-fold) (6,8). In addition, inheritance of the ⑀4 allele of apoE instead of the more common ⑀3 allele is the strongest genetic risk factor known for development of late-onset Alzheimer disease (9,10). Furthermore, apoE3containing lipoproteins have been reported to stimulate axon growth more efficiently than those containing apoE4 (11,12). Thus, it has been proposed that LpE assist in repairing neurons after injury.
Our laboratory has reported that astrocyte-derived LpE stimulate axon extension of retinal ganglion cells (RGCs; CNS neurons) by binding to a neuronal receptor of the low density lipoprotein receptor family on axons (13). Neurons in the CNS express several receptors of this superfamily for which apoE is a ligand (2,14,15). Some of these receptors can function both in the endocytosis of ligands (16) and in signaling pathways that are required for normal brain development (17,18). Recently, we demonstrated that glia-derived LpE strikingly protect cultured RGCs from apoptosis induced by withdrawal of trophic additives (19). The prevention of neuronal apoptosis was promoted by LpE binding to the multifunctional low density lipoprotein receptor-related protein-1 (LRP1) whereupon a signaling pathway was initiated that involved activation of protein kinase C␦ and inactivation of the pro-apoptotic kinase, glycogen synthase kinase-3␤ (19).
The aim of the present study was to dissect further the mechanism by which LpE protect RGC from apoptosis. We demonstrate that uptake of LpE is not required for the prevention of apoptosis. Furthermore, a signaling pathway induced upon binding of LpE to LRP1 requires the action of phospholipase C␥1 upstream of protein kinase C␦. Our data also show that glial LpE containing apoE3 are more protective against apoptosis than are apoE4-containing lipoproteins.

EXPERIMENTAL PROCEDURES
Materials-FK506, deltamethrin, cytochalasin D, and U73122 were purchased from Sigma. Two-day-old Sprague-Dawley rats were used for isolation of glial cells. Colonies of mice lacking endogenous apoE but expressing human apoE3 or human apoE4 (B6.Cg-Tg(GFAP-APOE3)37Hol Apoe tm1Unc /J and B6.Cg-Tg(GFAP-APOE4)1Hol Apoe tm1Unc /J, respectively) were established at the University of Alberta from breeding pairs of mice obtained from The Jackson Laboratory (Bar Harbor, ME).
Isolation and Culture of Cortical Glia-Glial cells were isolated from cerebral cortices of 2-day-old rats or mice according to the method of Gong et al. (21). Glia were cultured in Dulbecco's-modified Eagle's medium containing 10% fetal bovine serum. The cultures were highly enriched in astrocytes (13) (see Fig. 1).
Isolation of LpE from Glia-conditioned Medium-Glial cells were washed 3 times with phosphate-buffered saline and cultured for 3 days in basal medium (as used for culture of RGCs) lacking trophic additives. The conditioned medium was collected and centrifuged at room temperature for 10 min at 1000 ϫ g. The supernatant, designated "glia-conditioned medium," was subjected to ultracentrifugation on a discontinuous sucrose density gradient consisting of sucrose solutions of densities 1.30, 1.20, 1.10, and 1.006 g/ml at 4°C for 48 h at 160,000 ϫ g in a Beckman SW40-Ti rotor (13). Fractions were collected from the tops of the tubes and immunoblotted for apoE and apoJ, as described below. Fractions of densities 1.07-1.12 g/ml were combined and concentrated on an Amicon Ultra filter, 100-kDa molecular mass cut-off (Millipore, Bedford, MA). The amount of LpE used in the experiments was normalized to equal amounts of cholesterol (1 g/ml) as measured by gas-liquid chromatography (13).
Induction and Detection of Apoptosis-Apoptosis was induced in RGCs by withdrawal of trophic additives (forskolin, brain-derived neurotrophic factor, ciliary neurotrophic factor, basic fibroblast growth factor, and B27 supplement) from the culture medium (13,19). The RGCs were washed 3 times with basal medium lacking trophic additives (150 l/well) then incubated for 24 h in the same medium. For some experiments apoptosis was induced by the addition of 25 M H 2 O 2 with trophic additives containing B27 supplement AO depleted of antioxidants (Invitrogen) instead of B27 supplement for 24 h. The number of apoptotic neurons was determined by nuclear staining of fixed cells with Hoechst 33258 (1 g/ml, Invitrogen) (19). Fluorescent images were observed using a Leica DM IRE fluorescence microscope (Leica Microsystems, Bannockburn, IL). Fragmented or shrunken nuclei were counted as apoptotic.
Data are the averages Ϯ S.E. of a number of apoptotic nuclei as a percentage of total number of neurons. More than 300 neurons in each group were counted.
Preparation of Texas Red-labeled LpE-LpE were labeled with a FluoReporter Texas Red-X Protein labeling kit (Invitrogen) according to manufacturer's instructions. Briefly, 20 l of 1 M NaHCO 3 were added to 200 l of LpE suspension in phosphate-buffered saline, then mixed with Texas Red dye solution (1.92 l). The mixture was stirred for 1 h at room temperature in the dark. The Texas Red-labeled LpE were washed twice with phosphate-buffered saline using an Amicon Ultra filter (100-kDa molecular mass cut-off; Millipore).
RNA Silencing of Phospholipase C␥1-Negative control small interfering RNA (siRNA) (AllStars Negative siRNA) and two siRNAs specific for phospholipase C␥1 (catalogue numbers S101961939 and S1011961946) were purchased from Qiagen (Mississauga, ON, Canada). RGCs that had been cultured for 3-4 days were transfected with these siRNAs (20 pmol/well) using GeneSilencer siRNA Transfection Reagent (Gene Therapy Systems, San Diego, CA) according to the manufacturer's instructions. In brief, the siRNA and GeneSilencer Reagent were mixed for 10 min at room temperature then incubated with RGCs for 24 h. The medium was changed to fresh medium for an additional 24 h or for 48 h for immunoblotting experiments and assessment of apoptosis.
Lipid Composition of Glial Lipoproteins-Lipids were extracted (13, 22) from lipoproteins (200 g protein) and analyzed for the mass of unesterified cholesterol and phospholipids (g/mg protein) by gas-liquid chromatography (19).
Immunocytochemistry of Glia-Glial cells isolated from cerebral cortices were washed 3 times with phosphate-buffered saline, then fixed with 4% paraformaldehyde for 20 min. The cells were permeabilized in 0.2% Triton X-100 for 15 min at 4°C and blocked with 5% goat serum in phosphate-buffered saline for 1 h. The cells were incubated for 2 h at room temperature with mouse anti-bovine glial fibrillary acidic protein (dilution 1:500, BD Biosciences), rabbit anti-Iba1 (dilution 1:500, Wako, Osaka, Japan), mouse anti-human 2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase (dilution 1:250, Abcam, Cambridge, MA), or mouse anti-rat ␤III tubulin (dilution 1:500, Abcam) in phosphate-buffered saline containing 2% bovine serum albumin. The cells were washed 3 times with phosphate-buffered saline, then incubated with Alexa Fluor 488conjugated goat anti-rabbit IgG (dilution 1:200, Invitrogen) and Alexa Fluor 594-conjugated goat anti-mouse IgG (dilution 1:200, Invitrogen) for 1 h at room temperature. For assessment of cell survival, glia were incubated with Hoechst 33258 (1 g/ml, Invitrogen) for 15 min at room temperature, washed 3 times with phosphate-buffered saline, then mounted with Vectashield (Vector Laboratories, Inc., Burlingame, CA). Photographs were taken using an Olympus IX71 microscope (Tokyo, Japan). The different types of glia were assessed by quantifying the number of stained cells as a percentage of total number of cells. More than 400 cells were counted.

Internalization of Glia-derived LpE Is Not Required for Protection against Apoptosis-
We have previously demonstrated that glia-derived LpE activate an anti-apoptotic signaling pathway in RGCs upon binding to the low density LRP1 (19). Because LRP1 can internalize LpE via endocytosis and can also act as a signaling receptor (17, 18), we determined whether or not lipoprotein uptake is required for the neuroprotection. Glial cells were isolated from the cerebral cortex of 2-day-old rats (21) and cultured for 3 days in the absence of serum. These cultures contained 82.5% astrocytes, 16% microglia, 0.5% oligodendrocytes, and 1% neurons according to staining with fluorescence-labeled antibodies to marker proteins: glial fibrillary acidic protein (astrocytes), Iba1 (microglia), 2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase (oligodendrocytes), and ␤III tubu- The glia-conditioned medium was collected, and lipoproteins (density 1.07-1.12 g/ml) were isolated by sucrose density gradient ultracentrifugation (13,19). The fractions containing apoE were identified by immunoblotting, then combined and concentrated using a centrifuge filter. The concentrated fraction was designated as LpE. Proteins in glia-conditioned medium and in the LpE-rich fraction were stained with Coomassie Blue (Fig. 1D). ApoE secreted by the glia was highly enriched in the LpE fraction. The LpE were fluorescence-labeled with Texas Red and subsequently incubated with RGCs in the presence or absence of 20 M cytochalasin D, an agent that induces actin depolymerization and blocks endocytosis (24). After 3 h, the uptake of fluorescent LpE by RGCs was visualized by fluorescence microscopy. Cytochalasin D markedly reduced the number of fluorescence-positive cells (from 69.0 to 8.0%; Fig. 2A). Fluorescent LpE also non-specifically stained cell debris, resulting in the intensely stained small red dots visible in Fig.  2A. To determine whether inhibition of LpE uptake by cytochalasin D abolished the protective effect of LpE, we assessed the number of apoptotic nuclei in RGCs after 24 h by Hoechst staining (19). Cells with shrunken and fragmented nuclei were counted as apoptotic, and the number of apoptotic neurons is expressed as the percentage of total number of neurons. We have previously examined apoptosis of RGC under these conditions by both Hoechst staining and by staining with annexin V-fluorescein/propidium iodide (19). As in our previous studies (19), removal of trophic additives from the culture medium markedly increased the percentage of apoptotic nuclei (from ϳ8 to ϳ70%) (Fig. 2B). LpE almost completely prevented the neuronal death caused by removal of trophic additives. The presence of cytochalasin D did not reduce the ability of LpE to protect the neurons from apoptosis (Fig. 2B) despite the finding ( Fig. 2A) that cytochalasin D effectively blocked the uptake of Texas Redlabeled LpE. These experiments indicate that the internalization of glia-derived LpE is not required for LpE to exert their neuroprotective effect.
LpE Attenuate Neuronal Death Caused by Oxidative Stress-To determine whether neuronal death induced by other interventions could also be prevented by LpE, we exposed RGCs to oxidative stress by incubation of the cells for 24 h with hydrogen peroxide (25 M). To ensure a minimal antioxidant content of the culture medium, we used B27 supplement that had been depleted of antioxidants (Invitrogen catalog #10889) rather than the standard B27 supplement used in the other experiments. Neuronal survival was equivalent in the presence of either formulation of B27 supplement (Ͼ90%) (Fig. 3). Upon exposure of RGCs to H 2 O 2 for 24 h, ϳ80% of the neurons exhibited apoptotic nuclei according to Hoechst staining, and glial LpE significantly reduced neuronal death (Fig. 3). Thus, LpE protect neurons from apoptosis that is induced not only by withdrawal of trophic additives but also from death caused by oxidative stress. The magnitude of LpE-mediated protection from H 2 O 2 -induced apoptosis was less than for experiments in which trophic factors were removed (Fig. 2B). One potential explanation for this observation is that oxidative injury caused by H 2 O 2 might partially disable the neuroprotective function of LRP1. H 2 O 2 is known to oxidize lipids in lipoproteins, thereby partially masking the protective effect of LpE, and/or oxidized lipoproteins might themselves cause neuronal injury (25). In contrast to the results with H 2 O 2 , exposure of RGCs to tumor necrosis factor-␣, an inflammatory mediator, for up to 48 h at concentrations of up to 100 ng/ml did not cause significant neuronal death. Nor did LpE affect survival of RGCs exposed to this agent (data not shown).

Calcineurin Participates in Neuronal Apoptosis Induced by
Withdrawal of Trophic Additives-In our previous studies we started to define the anti-apoptotic signaling pathway(s) induced in RGCs upon binding of LpE to LRP1. We found that when trophic additives were removed from the culture medium of RGCs, phosphatidylserine became exposed on the cell surface of RGCs, and pro-apoptotic caspases were activated (19). An objective of the present study was to define in more detail the apoptotic pathway(s) that is/are induced in RGCs upon withdrawal of trophic additives. It has been reported that cleavage of the autoinhibitory domain of the protein phosphatase 2B, calcineurin, is enhanced in some chronic neurodegenerative diseases such as glaucoma (26). Moreover, the cleaved, active, form of calcineurin leads to apoptosis via a mitochondrial apoptotic pathway (27)(28)(29)(30). We, therefore, examined the role of calcineurin in neuronal apoptosis caused by removal of trophic additives. A rapid (within ϳ10 min) and transient cleavage of calcineurin to its active form (ϳ45 kDa) occurred upon withdrawal of trophic additives (Fig. 4A). Withdrawal of trophic additives from RGCs also caused pronounced neuronal death ( Fig. 4B) to an extent (ϳ80%) similar to that shown in Fig. 2B. To determine whether calcineurin participated in the apoptotic pathway initiated by removal of trophic additives, we tested whether or not calcineurin inhibitors prevented apoptosis of RGCs. The calcineurin inhibitors FK506 (1 M) (31) and deltamethrin (1 M) (32, 33) were dissolved in dimethyl sulfoxide and given to the neurons. Control cells were given an equivalent amount of dimethyl sulfoxide (0.4 l/ml) without inhibitor. Both calcineurin inhibitors prevented apoptosis of RGCs (Fig. 4B), indicating that activation of calcineurin is involved in an apoptotic pathway that is induced upon withdrawal of trophic additives. Furthermore, the amount of active calcineurin in RGCs cultured without trophic additives was reduced by LpE to the same level as in RGCs cultured in the presence of trophic additives (Figs. 4, C and D). Thus, LpE inhibit calcineurin activation, and inhibition of calcineurin prevents neuronal death. Consequently, both the calcineurin pathway and the glycogen synthase kinase-3␤ apoptotic pathway are inhibited by LpE.
Phospholipase C␥1 Contributes to the Neuroprotection Elicited by LpE-Activation of protein kinase C␦ occurs during an anti-apoptotic signaling pathway that is activated when LpE binds to LRP1 (19). Because diacylglycerols activate protein kinase C (34), we hypothesized that generation of diacylglycerols, via hydrolysis of phosphatidylinositol 4,5-bisphosphate by phospholipase C, might contribute to the neuroprotective effect of glial LpE. Removal of trophic additives from RGCs caused extensive neuronal death which was prevented by LpE ( Fig. 5A; also Fig. 2B). The addition of the phospholipase C inhibitor, U73122 (5 M), to trophic additive-deprived neurons completely abrogated the anti-apoptotic effect of LpE. Importantly, U73122 did not cause the death of RGCs that were provided with trophic additives (Fig. 5A). Thus, phospholipase C␥1 appears to be involved in the LpE-mediated protection of RGCs from apoptosis.
As an additional indication of the importance of phospholipase C␥1 in the LpE-mediated survival pathway, we reduced the expression of phospholipase C␥1 by RNA silencing. RGCs were cultured for 3-4 days, then transfected with either a control siRNA or one of two different siRNAs targeted to phospholipase C␥1. The RGCs were cultured for 48 or 72 h after which immunoblotting was performed with anti-phospholipase C␥1 antibodies. Neither of the phospholipase C␥1 siRNAs reduced the amount of phospholipase C␥1 protein significantly after 48 h (Fig. 5B). However, 72 h after transfection with either phospholipase C␥1-specific siRNA, the amount of phospholipase C␥1 was significantly reduced (Fig. 5B). In contrast, none of the siRNAs reduced the amount of the control protein ␤-actin (Fig. 5B). Quantification of immunoblots from three independent transfections with each siRNA construct (Figs. 5, C and D) revealed that 72 h after transfection the amount of phospholipase C␥1 protein was reduced by 35-50%.
To determine whether or not reduction in phospholipase C␥1 increased neuronal apoptosis, the siRNA-silenced RGCs were cultured with or without trophic additives and with or without glial LpE. Compared with control siRNA, neither phospholipase C␥1 siRNA increased the number of apoptotic nuclei in RGCs cultured in the presence of trophic additives (Fig. 5E). As expected, however, removal of trophic additives from each of the three types of transfected neurons increased the percentage of apoptotic nuclei (from ϳ20% to ϳ70%) (Fig. 5E). Although LpE prevented apoptosis of neurons transfected with control siRNA, the neuroprotection by LpE was abolished in neurons in which phospholipase C␥1 expression was reduced (Fig. 5E). These experiments demonstrate that phospholipase C␥1 provides a neuroprotective signal in the anti-apoptotic pathway initiated by LpE. Because of the established role of phospholipase C in activation of protein kinase C (34), these data suggest that phospholipase C␥1 acts upstream of protein kinase C in this anti-apoptotic pathway.
ApoE4-containing Lipoproteins Are Less Neuroprotective than ApoE3-containing Lipoproteins-In light of many reports that apoE4 is detrimental for neuronal functions (35)(36)(37), we compared the anti-apoptotic activity of glial LpE that contained either human apoE3 or human apoE4. We collected LpE secreted by astrocytes isolated from mice that lacked endogenous mouse apoE but expressed either human apoE3 or apoE4. According to immunoblotting, LpE isolated from astrocyteconditioned medium contained approximately equal amounts of apoE and also similar amounts of apoJ (Fig. 6). We also analyzed the lipid content of the two types of glial LpE. Although phospholipids comprise the major lipid component of LpE, cholesterol is also abundant ( Table 1). The lipid content (g/mg protein) of apoE3-and apoE4-containing lipoproteins was indistinguishable and was also similar to that of rat glial LpE, although mouse LpE contained more phospholipid relative to cholesterol than did rat LpE ( Table 1). The isolated lipoproteins that contained apoE3 or apoE4 were supplied to RGCs from which trophic additives had been withdrawn; control cultures were provided with trophic additives but were not given LpE. The apoE3-containing lipoproteins effectively protected the RGCs from apoptosis, whereas the apoE4-containing lipoproteins were significantly less protective (Fig. 6B).

DISCUSSION
Neuronal apoptosis is a characteristic of neurodegenerative disorders such as Alzheimer disease, Parkinson disease, and Niemann-Pick Type C disease. In the present study we provide novel information on mechanisms by which LpE protect neurons from apoptosis induced by removal of trophic additives. Consistent with our previous observation that LpE promote survival of RGCs (19), neuronal and behavioral defects have been observed in apoE knock-out mice, particularly after injury (38) and during aging (39,40). Thus, the LpE-induced anti-apoptotic signaling pathway that we have identified might protect CNS neurons from apoptosis in some neurodegenerative disorders. Levels of neurotrophic factors such as brain-derived neurotrophic factor are decreased in the brains of individuals with Alzheimer disease and Parkinson disease (41,42). Interestingly, the neuroprotective action of LpE in RGC is not restricted to apoptosis caused by withdrawal of trophic additives as our studies show that neuronal death caused by oxidative stress (exposure to H 2 O 2 ) is also attenuated by LpE.
The presence of apoE on the lipoproteins is necessary for their anti-apoptotic properties. Moreover, association of apoE with lipid is required for initiation of the anti-apoptotic signaling pathway, presumably by maintaining an appropriate receptor binding conformation of the protein (43). Our data show that cholesterol is not required in LpE for the neuroprotection because reconstituted LpE completely lacking cholesterol effectively prevent apoptosis of RGCs (19). In addition to receptors of the low density lipoprotein receptor superfamily acting as endocytosis receptors (16) several of these receptors (for example, the apoE receptor-2 and the very low density lipoprotein receptor (44)) have been implicated in signaling pathways in the brain, particularly during development. An important conclusion from the present study is that the ability of LpE to protect RGCs from apoptosis is independent of internalization of the lipoprotein particles. This finding is consistent with the idea that the major anti-apoptotic pathway induced by LpE is a signaling pathway initiated by binding of LpE to LRP1 on the cell surface.
Involvement of Phospholipase C␥1 in Protection of RGCs from Apoptosis-LpE bind to LRP1, a multifunctional receptor of the low density lipoprotein receptor superfamily, that is expressed in RGCs. Subsequently, a signaling cascade is initiated in which protein kinase C␦ is activated and the pro-apoptotic kinase, glycogen synthase kinase-3␤, is phosphorylated and inactivated. Many studies have implicated glycogen synthase kinase-3␤ as a key contributor to neuronal apoptosis (45)(46)(47)(48). Inhibition of glycogen synthase kinase-3␤ reduces tauropathy (49) as well as production of the A␤ peptide (50,51), suggesting that inhibition of glycogen synthase kinase-3␤ is a potential therapeutic target for treatment of neurodegenerative disorders. Our current data demonstrate that the binding of LpE to LRP1 activates phospholipase C␥1, suggesting that this lipase acts upstream of protein kinase C␦ in the anti-apoptotic signaling cascade initiated by LpE. Phospholipase C␥1 produces diacylglycerols and inositol 1,4,5-trisphosphate upon hydrolysis of phosphatidylinositol 4,5-bisphosphate (34). Diacylglycerols activate members of the protein kinase C family, such as protein kinase C␦. We used inhibitors of phospholipase C␥1 as well as RNA silencing to demonstrate that phospholipase C␥1 is required for the LpE-mediated protection of RGCs from apoptosis. Although the amount of phospholipase C␥1 protein was reduced by only 35-50% in the RNA knockdown experiments, the LpE-mediated neuroprotection was completely abolished, highlighting the importance of this phospholipase in protecting RGCs from apoptosis. Several other reports have demonstrated that phospholipase C␥1 is a component of signaling pathways that increase neuronal survival. For example, phospholipase C␥1 has been implicated in signaling pathways induced by neurotrophins such as nerve growth factor and brain-derived neurotrophic factor (for review, see Ref. 52) as well as vascular endothelial growth factor (for review, see Ref. 53).
Involvement of Calcineurin in Neuronal Apoptosis-We previously showed that withdrawal of trophic additives caused exposure of phosphatidylserine on the surface of RGCs and that FIGURE 6. ApoE4-containing LpE less effectively protect RGCs against apoptosis than do apoE3-containing LpE. Cortical glia were isolated from mice lacking endogenous apoE but expressing human apoE3 or human apoE4. LpE were isolated from conditioned medium. A, equal amounts of LpE protein (10 g) were separated by polyacrylamide gel electrophoresis and immunoblotted with antibodies directed against apoE and apoJ. The experiment was repeated two additional times with similar results. B, LpE secreted by mouse glia expressing human apoE3 or apoE4 were given to RGCs for 24 h in medium lacking trophic additives (BM(Ϫ)). Control cultures were supplied with trophic additives (BM(ϩ)). The number of apoptotic neurons was determined by Hoechst staining and is given as percentage of total number of neurons. Data are the means Ϯ S.E. from four independent experiments. *, p Ͻ 0.005 for BM(Ϫ) versus BM(Ϫ) ϩ apoE3 and for BM(Ϫ) ϩ apoE4. #, p Ͻ 0.001 for apoE3 versus apoE4. Statistical analysis was performed using oneway analysis of variance followed by Bonferroni's multiple comparison. caspases were involved in this apoptotic pathway (19). We now show that withdrawal of trophic support from RGCs activates calcineurin, a protein phosphatase 2B. We also demonstrate that calcineurin inhibitors prevent neuronal death. Thus, calcineurin appears to play a role in the apoptotic pathway(s) induced by removal of trophic additives from RGCs. Activation of calcineurin has been reported to induce the dephosphorylation of BAD (a pro-apoptotic member of the Bcl-2 family) and activate caspase-3, thereby causing apoptosis in several types of cells including neurons (27)(28)(29). Moreover, FK506 and cyclosporine (inhibitors of calcineurin A) block mitochondria-mediated apoptosis in primary cortical neurons (54,55) and glutamate-induced apoptosis in astrocytes (56). These data suggest that calcineurin plays an important role in apoptosis in the CNS. We now show that LpE attenuate the activation of calcineurin that occurs upon withdrawal of trophic additives from RGCs, although we cannot distinguish between calcineurin and glycogen synthase kinase-3␤ acting in the same or independent apoptotic pathways (Fig. 7). Further details of the link between activation of LRP1 and attenuation of calcineurin activation remain to be established. However, we speculate that reduction in neuronal calcium levels, induced by activation of LRP1, inhibits calcineurin cleavage (57,58). Moreover, the calciumdependent cysteine protease, calpain, cleaves full-length calcineurin to the constitutively active form (45 kDa) (59). Thus, a reduction in intracellular calcium levels induced by activation of LRP1 might prevent apoptosis by inhibiting calcineurin cleavage. We conclude that LpE protect neurons from death mediated by both the calcineurin pathway and the glycogen synthase kinase-3␤ pathway (Fig. 7). Our observations provide additional support for the idea that calcineurin-mediated apoptosis can be a component in nerve injuries and neurodegenerative diseases (23, 28, 60 -62).
ApoE Isoforms and Neuronal Apoptosis-Inheritance of the ⑀4, rather than the more common ⑀3 allele of apoE is the strongest known genetic risk factor for development of Alzheimer disease (9). We, therefore, compared the ability of physiologically relevant apoE3-and apoE4-containing lipoproteins to protect RGCs from apoptosis induced by withdrawal of trophic additives. LpE secreted by astrocytes isolated from mice expressing human apoE3 or apoE4, but lacking endogenous mouse apoE, were given to RGCs. The apoE3-containing lipoproteins protected RGCs from apoptosis, whereas the apoE4-containing lipoproteins were significantly less protective (Fig. 6). To determine whether the difference in protection provided by the two types of LpE were because of gross differences in lipid composition of the LpE, we measured the cholesterol and phospholipid content of the LpE and found no significant differences between apoE3-and apoE4-containing LpE. These observations are consistent with our previous observation that reconstituted high density lipoprotein particles that contained only phospholipids and recombinant apoE4 were less neuroprotective for RGCs than were reconstituted apoE3containing particles (19). We speculate that the differential protection afforded by apoE3-and apoE4-containing glial lipoproteins might contribute to the extensive neurodegeneration that occurs in late-onset Alzheimer disease patients that express apoE4.
In conclusion, we have demonstrated that LpE protect neurons from apoptosis via a signaling mechanism that does not require internalization of the LpE particles. The signaling pathway that occurs upon the binding of LpE to LRP1 on RGCs involves activation of phospholipase C␥1 and subsequent activation of protein kinase C␦. This kinase directly or indirectly phosphorylates and inactivates glycogen synthase kinase-3␤ and prevents apoptosis, as proposed in the model depicted in Fig. 7. Furthermore, withdrawal of trophic additives from RGCs activates a pro-apoptotic pathway that involves calcineurin; this activation is also prevented by LpE (Fig. 7). Finally, we show that physiologically relevant, astrocyte-derived apoE4-containing lipoproteins are less able to protect neurons from apoptosis than are apoE3-containing lipoproteins.